Nagi; Arwinder S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Nagi; Arwinder S..The latest application filed is for "micronized tanaproget, compositions, and methods of preparing the same".

Company Profile

0.10.16

Nagi; Arwinder S. - Moorpark CA
Nagi; Arwinder S. - Thiells NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compositions containing micronized tanaproget prepared by wet granulation Grant 8,791,109 - Nagi , et al. July 29, 2	2014-07-29
Micronized tanaproget, compositions, and methods of preparing the same Grant 8,772,271 - Nagi , et al. July 8, 2	2014-07-08
Micronized Tanaproget, Compositions, And Methods Of Preparing The Same App 20130251807 - Nagi; Arwinder S. ; et al.	2013-09-26
Micronized tanaproget and compositions containing same Grant 8,513,240 - Nagi , et al. August 20, 2	2013-08-20
Compositions Containing Micronized Tanaproget Prepared By Wet Granulation App 20130142838 - Nagi; Arwinder S. ; et al.	2013-06-06
Micronized tanaproget, compositions, and methods of preparing the same Grant 8,450,312 - Nagi , et al. May 28, 2	2013-05-28
Compositions containing micronized tanaproget prepared by wet granulation Grant 8,343,965 - Nagi , et al. January 1, 2	2013-01-01
Bazedoxifene Formulations With Antioxidants App 20110165241 - Agrawal; Anjali ; et al.	2011-07-07
Micronized Tanaproget and Compositions Containing Same App 20110091539 - Nagi; Arwinder S. ; et al.	2011-04-21
Micronized tanaproget, compositions, and methods of preparing the same Grant 7,767,668 - Nagi , et al. August 3, 2	2010-08-03
Micronized Tanaproget, Compositions, and Methods of Preparing the Same App 20100189789 - Nagi; Arwinder S. ; et al.	2010-07-29
Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using Same App 20100062058 - Warne; Nicholas W. ; et al.	2010-03-11
Pharmaceutical Formulations Of An Anhydrous Crystal Form Of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol App 20070208069 - Krishnan; Mahesh K. ; et al.	2007-09-06
Liquid and Semi-Solid Pharmaceutical Formulations and Processes App 20070207201 - Krishnan; Mahesh K. ; et al.	2007-09-06
Pharmaceutical Formulations Of A Monohydrate Crystal Form Of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol App 20070207202 - Krishnan; Mahesh K. ; et al.	2007-09-06
Tablet Formulations and Processes App 20070208067 - Krishnan; Mahesh K. ; et al.	2007-09-06
Pharmaceutical dosage forms and compositions App 20070099931 - Ghosh; Krishnendu ; et al.	2007-05-03
Formulations of conjugated estrogens and bazedoxifene App 20070003623 - Chatlapalli; Ramarao S. ; et al.	2007-01-04
Micronized tanaproget, compositions, and methods of preparing the same App 20060246135 - Nagi; Arwinder S. ; et al.	2006-11-02
Compositions containing micronized tanaproget prepared by wet granulation App 20060247234 - Nagi; Arwinder S. ; et al.	2006-11-02
Pharmaceutical dosage forms and compositions App 20050215561 - Ghosh, Krishnendu ; et al.	2005-09-29
Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using same App 20040126358 - Warne, Nicholas W. ; et al.	2004-07-01
Rapamycin formulations for oral administration Grant 5,989,591 - Nagi November 23, 1	1999-11-23
Rapamycin formulations for oral administration Grant 5,985,325 - Nagi November 16, 1	1999-11-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.